Form 8-K · Current Report · Filed 2026-05-07
Kenvue Reports Q1 2026 Earnings Beat with 4.5% Net Sales Increase
Kenvue Inc. announced its financial results for the fiscal first quarter ended March 29, 2026, reporting a 4.5% increase in net sales, driven by organic sales growth of 0.7% and a foreign currency benefit of 3.8%. The company saw improvements in gross profit margin, operating income margin, and earnings per share (EPS), with diluted EPS increasing 47% to $0.25 and adjusted diluted EPS increasing 33% to $0.32. Kenvue also provided an update on the pending transaction with Kimberly-Clark and the 2026 Restructuring Initiative.
- Filer
- Kenvue Inc. KVUE · NYSE
- Filed
- Accession
- 0001944048-26-000097
- CIK
- 0001944048
- Signal
- High impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$17.68
Next session
-0.5%
Since filing
+8.8%
Latest close
$19.24
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from KVUE reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, KVUE insiders reported 13 Form 4 transactions — net buying of $1.3M.
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Never miss another KVUE filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.